MRFF EMCR Initiative - Early to Mid-Career Researchers Grant
2026-08-19 17:00 (Australia/Sydney)
The Medical Research Future Fund (MRFF) –2026 Early to Mid-Career Researchers Grant Opportunity will support research to build and grow research capacity and capability in Australia by supporting Early to Mid-Career Researchers (EMCRs) to continue their health and medical research careers.
The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

Stream 1 (Incubator): conduct early stage, small scale research, led by early career researchers, that seeks to assess the potential and feasibility of novel strategies to address a critical or intractable health issue in one or more Priority Populations.
Stream 2 (Accelerator): establish a large-scale interdisciplinary research program, led by mid-career researchers, that drives implementation of substantial improvements to health care and/or health system effectiveness for one or more Priority Populations.
Stream 3 (Targeted Call for Research): utilise co-funding to accelerate the translation of research led by early or mid-career researchers into policy and practice. (Note: a priority population focus is not required).

The intended outcome of the research is to improve the health and wellbeing of Australians by:

Stream 1 (Incubator): supporting early career researchers to develop innovative solutions for addressing significant health challenges in Priority Populations.
Stream 2 (Accelerator): supporting mid-career researchers to transform health practice and/or policy for Priority Populations.
Stream 3 (Targeted Call for Research): supporting early to mid-career researchers to translate new health solutions into practice.

Key Dates:
Minimum data due: 22 July 2026
Applications close: 19 August 2026
Grant activity timeframe: February 2027
SEE GRANT GUIDELINESSEE WEBSITE

TOUR DE CURE Annual Grants
2026-08-21 17:00 (Australia/Sydney)
We are proud to open a new Annual Grants Round in 2026, made possible by the continued support of our community, partners, and fundraisers.
This year’s Grant Round is open to applications in the following categories:
• Early Career Research Grant
• PhD Scholarship
• Prof Richard Scolyer Award for Brain Cancer Research for Early, Mid and Senior Career Researchers
The Tour de Cure Grants Committee follows an ethical, independent, and transparent selection process when reviewing applications.
We are committed to funding innovation and excellence, using our resources to support the best Australian-based projects and researchers. As a cancer-agnostic organisation, we consider applications across all cancer types.
Demonstrating a rigorous selection process, choosing the strongest projects, and maintaining sound project governance – all grant applications are assessed on merit.
An EOI (Expression of Interest) is required for all research grant categories listed. EOIs are reviewed in Round One by the Tour de Cure Grants Committee. Successful applicants are then invited to submit a full grant application in Round Two, which is assessed in detail by the Grants Committee who then makes recommendations to the TDC Board for final decisions in December.
Institutions supporting individual researchers may submit no more than two applications per grant category. This limit applies even where an intermediary body, such as a foundation, applies on behalf of the researcher. There is no limit on the number of PhD Scholarship applications but please be mindful of your submission numbers.

Key Dates:
Expressions of Interest open: 1 August 2026
Expressions of Interest close: 21 August 2026
Expressions of Interest outcomes notified: 8 October 2026
Full grant applications open (by invitation): 9 October 2026
Full grant applications close: 24 October 2026
SEE GRANT GUIDELINESSEE WEBSITE

MRFF International Clinical Trial Collaborations
2026-09-16 17:00 (Australia/Sydney)
The objective of the Medical Research Future Fund (MRFF) – 2026 International Clinical Trial Collaborations Grant Opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

Promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.
Provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in ‘usual care’ settings, which will support a decision on whether to deliver the intervention in an Australian setting.

The anticipated outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care.
Please note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only.

Key Dates:
Minimum data due: 19 August 2026
Applications close: 16 September 2026
SEE GRANT GUIDELINESSEE WEBSITE

CDMRP Melanoma Research Program
2026-10-14 17:00 (America/Halifax)
The Melanoma Research Program (MRP) released program announcements for the following funding opportunities:

· Focused Program Award – Rare Melanomas
This award supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.
· Idea Award
The Idea Award supports innovative, exploratory, high-risk/potentially high-reward research. Novelty and innovation are expected to be key aspects of the proposed project. By the end of the Idea Award funding period, the anticipated outcomes of successful efforts should establish proof of principle and obtain preliminary data to secure follow-on funding.
· Melanoma Academy Scholar Award
Supports the addition of independent, early career investigators (Scholars) who are no more than seven years from their initial faculty appointment to the Melanoma Research Program (MRP) Melanoma Academy. The Melanoma Academy is a unique, interactive virtual academy focused on bringing together established investigators and Scholars to develop a network of successful, highly productive melanoma researchers in a collaborative research and career development environment.
· Survivorship Research Award
The award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.
· Team Science Award
Supports a broad range of hypothesis-driven, multidisciplinary studies that have a short-term goal of advancing the state of the science in melanoma research and/or patient care. Team science is a synergistic effort that harnesses techniques, approaches and perspectives from multiple disciplines and/or therapeutic areas to address complex, multi-dimensional problems that will impact patient outcomes.
Key Dates:
Submission Deadline (Pre-application-Pre-Proposal): 13 July 2026
Focused Program Award – Rare Melanomas
Idea Award
Team Science Award
Submission Deadline (Pre-application-Pre-Proposal): 22 September 2026
Melanoma Academy Scholar Award
Survivorship Research Award
Application Submission Deadline: 14 October 2026

SEE GRANT GUIDELINESSEE WEBSITE

NHMRC Partnership Projects
2026-11-11 17:00 (Australia/Sydney)
The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret the findings and implement the findings into policy and practice.

Partnership Projects create partnerships among decision makers, policy makers, managers, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery, organisation, funding and access to health services.
Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes.
The objectives of the Partnership Project scheme are to:
• Meet the need for more effective integration of research evidence into health policy and service delivery
• Create partnerships among policy makers, managers, service providers and researchers
• Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care
• Be highly responsive to the priorities of government, the community and health professionals
• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations.

Key Dates for Peer Review Cycle 2:
Applications open: 19 March 2026
NHMRC-approved Administering Institutions waiver due: 8 July 2026
Minimum data due: 22 July 2026
Applications close: 5 August 2026
Peer review meetings: 17-19 November 2026
Key Dates for Peer Review Cycle 3:
Applications open: 23 July 2026
NHMRC-approved Administering Institutions waiver due: 14 October 2026
Minimum data due: 28 October 2026
Applications close: 11 November 2026
Peer review meetings: 2-4 March 2027
SEE GRANT GUIDELINESSEE WEBSITE

MRFF 2022 Frontier Health and Medical Research Grant
2027-03-31 17:00 (Australia/Sydney)
This grant program will support researchers to pursue big ideas to develop new products and interventions and implement these into clinical practice, benefiting patients, clinicians, and the health system.
This grant opportunity offers funding to support medical research and medical innovation programs of research (up to $25 million per program) that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re‑purpose existing health technologies in a novel way.
The initial application process to secure funding through this grant opportunity will be conducted in two stages:

expression of interest (EOI) – outlining a proposed program of research comprising of a series of linked projects with a 10-year time horizon
full application, (invitation only – following EOI) for a project of up to 5 years under the program of research.

Applicants may propose to commence research at any stage in the research pipeline from proof-of-concept, with the intention of achieving full implementation of the proposed technology in 10 years.
Funding for subsequent projects under the program of research that continue to progress the technology towards full implementation can be sought by submitting additional full applications to this grant opportunity (i.e. applicants do not need to recommence with an EOI). These applications may be submitted by invitation only.

Key Dates:
Expressions of Interest close: 31 March 2027
Last grants awarded by: 30 June 2028
SEE GRANT GUIDELINESSEE WEBSITE
